Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Cancer- and cancer treatment-associated cognitive change: an update on the state of the science.

Ahles TA, Root JC, Ryan EL.

J Clin Oncol. 2012 Oct 20;30(30):3675-86. doi: 10.1200/JCO.2012.43.0116. Epub 2012 Sep 24. Review.

2.

Brain vulnerability to chemotherapy toxicities.

Ahles TA.

Psychooncology. 2012 Nov;21(11):1141-8. doi: 10.1002/pon.3196. Epub 2012 Oct 1. Review.

3.

Cancer, cognitive impairment, and meditation.

Biegler KA, Chaoul MA, Cohen L.

Acta Oncol. 2009;48(1):18-26. doi: 10.1080/02841860802415535. Review.

PMID:
19031161
4.

Cognitive dysfunction among cancer survivors.

Asher A.

Am J Phys Med Rehabil. 2011 May;90(5 Suppl 1):S16-26. doi: 10.1097/PHM.0b013e31820be463. Review.

PMID:
21765260
5.

Cognitive effects of cancer and its treatments at the intersection of aging: what do we know; what do we need to know?

Mandelblatt JS, Hurria A, McDonald BC, Saykin AJ, Stern RA, VanMeter JW, McGuckin M, Traina T, Denduluri N, Turner S, Howard D, Jacobsen PB, Ahles T; Thinking and Living With Cancer Study.

Semin Oncol. 2013 Dec;40(6):709-25. doi: 10.1053/j.seminoncol.2013.09.006. Review.

6.

Cognitive changes in cancer survivors.

Nail LM.

Cancer Nurs. 2006 Mar-Apr;29(2 Suppl):48-54. Review. No abstract available.

PMID:
16779956
7.

[Changes of neurocognitive functions as result of cancer treatment in children and adolescents].

Vlcková I, Pavelková K, Kepák T, Pilát M, Bajciová V, Mazánek P, Sterba J, Jelínek M.

Klin Onkol. 2008;21(5):294-302. Review. Czech.

PMID:
19202961
8.

Breast cancer chemotherapy-related cognitive dysfunction.

Ahles TA, Saykin AJ.

Clin Breast Cancer. 2002 Dec;3 Suppl 3:S84-90. Review.

PMID:
12533268
9.
10.
11.

Neuropsychological sequelae of non-central nervous system cancer and cancer therapy.

Wefel JS, Witgert ME, Meyers CA.

Neuropsychol Rev. 2008 Jun;18(2):121-31. doi: 10.1007/s11065-008-9058-x. Epub 2008 Apr 16. Review.

PMID:
18415683
12.

Cognitive side-effects of adjuvant treatments.

Burstein HJ.

Breast. 2007 Dec;16 Suppl 2:S166-8. Epub 2007 Aug 23. Review.

PMID:
17719225
13.

Is cognitive dysfunction a complication of adjuvant chemotherapy in the older patient with breast cancer?

Hurria A, Lachs M.

Breast Cancer Res Treat. 2007 Jul;103(3):259-68. Epub 2007 Apr 12. Review.

PMID:
17429718
14.

Neurocognitive changes in cancer survivors.

Correa DD, Ahles TA.

Cancer J. 2008 Nov-Dec;14(6):396-400. doi: 10.1097/PPO.0b013e31818d8769. Review.

PMID:
19060604
15.

Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.

Cheung YT, Chui WK, Chan A.

Crit Rev Oncol Hematol. 2012 Jul;83(1):99-111. doi: 10.1016/j.critrevonc.2011.09.001. Epub 2011 Oct 19. Review.

PMID:
22015329
16.

An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.

Cheung YT, Tan EH, Chan A.

Support Care Cancer. 2012 Jul;20(7):1361-75. doi: 10.1007/s00520-012-1445-4. Epub 2012 Apr 5. Review.

PMID:
22476439
17.

Cognitive function in breast cancer survivors.

Vardy J.

Cancer Treat Res. 2009;151:387-419. doi: 10.1007/978-0-387-75115-3_24. Review. No abstract available.

PMID:
19593525
18.

Cognitive dysfunction and cancer: which consequences in terms of disease management?

Joly F, Rigal O, Noal S, Giffard B.

Psychooncology. 2011 Dec;20(12):1251-8. doi: 10.1002/pon.1903. Epub 2011 Jan 21. Review.

PMID:
21254307
19.

Chemotherapy-related cognitive dysfunction.

Wefel JS, Schagen SB.

Curr Neurol Neurosci Rep. 2012 Jun;12(3):267-75. doi: 10.1007/s11910-012-0264-9. Review. Erratum in: Curr Neurol Neurosci Rep. 2012 Jun;12(3):340.

PMID:
22453825
20.

It's not over when it's over: long-term symptoms in cancer survivors--a systematic review.

Harrington CB, Hansen JA, Moskowitz M, Todd BL, Feuerstein M.

Int J Psychiatry Med. 2010;40(2):163-81. Review.

PMID:
20848873
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk